The digital pathology market size has grown rapidly in recent years. It will grow from $1.42 billion in 2025 to $1.68 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to increasing digitization of pathology laboratories, expansion of cancer diagnostics, growing adoption of telepathology, rising demand for standardized pathology workflows, improved availability of digital scanners.
The digital pathology market size is expected to see rapid growth in the next few years. It will grow to $3.29 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to increasing investments in computational pathology, rising demand for precision diagnostics, expansion of digital pathology in drug discovery, growing integration of AI in disease diagnosis, increasing focus on interoperability and data sharing. Major trends in the forecast period include increasing adoption of whole slide imaging systems, rising use of ai-based image analysis software, growing expansion of remote pathology services, integration of cloud-based pathology platforms, enhanced focus on workflow automation.
The rising incidence of cancer is significantly contributing to the expansion of the digital pathology market. As populations age, the likelihood of developing cancer increases due to cellular changes and prolonged exposure to various risk factors. Additionally, lifestyle choices such as smoking, poor diet, insufficient physical activity, and excessive alcohol consumption further elevate cancer risk. Digital pathology facilitates quicker diagnosis and treatment of cancer, making it a vital tool in managing this growing health concern. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization focused on cancer advocacy, reported that the number of cancer cases rose to 2,001,140 in 2024, up from 1,958,310 in 2023, marking an increase of 2.19%. Consequently, the rising prevalence of cancer is expected to drive the growth of the digital pathology market in the future.
Leading players operating in the digital pathology market are emphasizing the development of advanced solutions, such as collaborative AI-powered laboratory networks, to improve data sharing and drive clinical innovation. Collaborative AI-powered lab networks consist of interconnected pathology laboratories that leverage shared AI systems and data platforms to promote standardization, faster turnaround times, and the generation of real-world evidence. For example, in July 2025, PathAI, a US-based provider of digital pathology and AI solutions, introduced its Precision Pathology Network powered by the AISight image management system. This network links anatomic pathology laboratories with biopharmaceutical partners and enables early access to AI algorithms, while offering secure frameworks for sharing de-identified pathology data to support translational research. Participating laboratories gain access to PathAI’s advanced algorithms, including MET-Predict, and can monetize real-world pathology data, while biopharmaceutical companies benefit from a consistent flow of clinical and molecular data for biomarker research and precision drug development.
In August 2025, Tempus AI, Inc., a US-based provider of AI-enabled precision medicine and data-driven diagnostics, acquired Paige, a digital pathology company, for $81.25 million. Through this acquisition, Tempus seeks to expand its pathology data assets, enhance its AI research capabilities, and establish a strong presence in digital pathology to accelerate the development of oncology-focused AI models. Paige, a US-based company, develops AI-driven pathology applications and maintains an extensive dataset of nearly 7 million clinically annotated digitized pathology slides.
Major companies operating in the digital pathology market are Danaher Corporation, Hoffmann-La Roche Ltd, Koninklijke Philips N.V, Hamamatsu Photonics K.K, 3DHISTECH Ltd, Olympus Corporation, Nikon Corporation, Leica Biosystems, Ventana Medical Systems, Sectra AB, Visiopharm A/S, Indica Labs Inc, PathAI, Paige.ai, Ibex Medical Analytics, Aiforia Technologies, Proscia, Inspirata Inc, Huron Digital Pathology, Akoya Biosciences, Aperio Digital Pathology, PerkinElmer, Definiens AG, Digipath, Apollo Enterprise Imaging Corp.
North America was the largest region in the digital pathology market in 2025. Asia-Pacific was the second-largest region in the digital pathology market. The regions covered in the digital pathology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital pathology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the digital pathology market by increasing costs of imported slide scanners, optical components, high-resolution cameras, computing hardware, and specialized software systems. Pharmaceutical companies, hospitals, and research institutes in North America and Europe are most affected due to dependence on imported advanced imaging hardware, while Asia-Pacific faces cost pressures on scanner manufacturing and exports. These tariffs are increasing capital investment requirements and slowing system upgrades. However, they are also encouraging local hardware assembly, regional software development, and increased adoption of cloud-based pathology solutions that reduce reliance on imported infrastructure.
The digital pathology market research report is one of a series of new reports that provides digital pathology market statistics, including digital pathology industry global market size, regional shares, competitors with a digital pathology market share, detailed digital pathology market segments, market trends and opportunities, and any further data you may need to thrive in the digital pathology industry. This digital pathology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Digital pathology involves utilizing digital imaging for pathology procedures, converting glass slides into high-resolution digital images using slide scanner hardware, software, and related services. These digital images are viewable, manageable, and analyzable on computer or mobile screens.
Key products in digital pathology include scanners, software, communication systems, and storage systems. Scanners utilize microscopic array technology to create three-dimensional digital representations of pathology slides for viewing and automated image analysis. Software aids in transferring data to digital formats for image review, analysis, and tissue image analysis. Communication systems facilitate interaction between various components for slide acquisition, storage, viewing, and real-time telepathology with remote colleagues. Storage systems involve digital archives for long-term sample analysis and predictive analytics. Pathology branches into human pathology and veterinary pathology. Digital pathology finds application across pharmaceutical & biotechnology companies, hospitals, reference laboratories, academic & research institutes. Its uses encompass drug discovery, disease diagnosis, teleconsultation, and training & education purposes.
The digital pathology market consists of the sales of slide scanners, software, and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The digital pathology market size is expected to see rapid growth in the next few years. It will grow to $3.29 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to increasing investments in computational pathology, rising demand for precision diagnostics, expansion of digital pathology in drug discovery, growing integration of AI in disease diagnosis, increasing focus on interoperability and data sharing. Major trends in the forecast period include increasing adoption of whole slide imaging systems, rising use of ai-based image analysis software, growing expansion of remote pathology services, integration of cloud-based pathology platforms, enhanced focus on workflow automation.
The rising incidence of cancer is significantly contributing to the expansion of the digital pathology market. As populations age, the likelihood of developing cancer increases due to cellular changes and prolonged exposure to various risk factors. Additionally, lifestyle choices such as smoking, poor diet, insufficient physical activity, and excessive alcohol consumption further elevate cancer risk. Digital pathology facilitates quicker diagnosis and treatment of cancer, making it a vital tool in managing this growing health concern. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization focused on cancer advocacy, reported that the number of cancer cases rose to 2,001,140 in 2024, up from 1,958,310 in 2023, marking an increase of 2.19%. Consequently, the rising prevalence of cancer is expected to drive the growth of the digital pathology market in the future.
Leading players operating in the digital pathology market are emphasizing the development of advanced solutions, such as collaborative AI-powered laboratory networks, to improve data sharing and drive clinical innovation. Collaborative AI-powered lab networks consist of interconnected pathology laboratories that leverage shared AI systems and data platforms to promote standardization, faster turnaround times, and the generation of real-world evidence. For example, in July 2025, PathAI, a US-based provider of digital pathology and AI solutions, introduced its Precision Pathology Network powered by the AISight image management system. This network links anatomic pathology laboratories with biopharmaceutical partners and enables early access to AI algorithms, while offering secure frameworks for sharing de-identified pathology data to support translational research. Participating laboratories gain access to PathAI’s advanced algorithms, including MET-Predict, and can monetize real-world pathology data, while biopharmaceutical companies benefit from a consistent flow of clinical and molecular data for biomarker research and precision drug development.
In August 2025, Tempus AI, Inc., a US-based provider of AI-enabled precision medicine and data-driven diagnostics, acquired Paige, a digital pathology company, for $81.25 million. Through this acquisition, Tempus seeks to expand its pathology data assets, enhance its AI research capabilities, and establish a strong presence in digital pathology to accelerate the development of oncology-focused AI models. Paige, a US-based company, develops AI-driven pathology applications and maintains an extensive dataset of nearly 7 million clinically annotated digitized pathology slides.
Major companies operating in the digital pathology market are Danaher Corporation, Hoffmann-La Roche Ltd, Koninklijke Philips N.V, Hamamatsu Photonics K.K, 3DHISTECH Ltd, Olympus Corporation, Nikon Corporation, Leica Biosystems, Ventana Medical Systems, Sectra AB, Visiopharm A/S, Indica Labs Inc, PathAI, Paige.ai, Ibex Medical Analytics, Aiforia Technologies, Proscia, Inspirata Inc, Huron Digital Pathology, Akoya Biosciences, Aperio Digital Pathology, PerkinElmer, Definiens AG, Digipath, Apollo Enterprise Imaging Corp.
North America was the largest region in the digital pathology market in 2025. Asia-Pacific was the second-largest region in the digital pathology market. The regions covered in the digital pathology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital pathology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the digital pathology market by increasing costs of imported slide scanners, optical components, high-resolution cameras, computing hardware, and specialized software systems. Pharmaceutical companies, hospitals, and research institutes in North America and Europe are most affected due to dependence on imported advanced imaging hardware, while Asia-Pacific faces cost pressures on scanner manufacturing and exports. These tariffs are increasing capital investment requirements and slowing system upgrades. However, they are also encouraging local hardware assembly, regional software development, and increased adoption of cloud-based pathology solutions that reduce reliance on imported infrastructure.
The digital pathology market research report is one of a series of new reports that provides digital pathology market statistics, including digital pathology industry global market size, regional shares, competitors with a digital pathology market share, detailed digital pathology market segments, market trends and opportunities, and any further data you may need to thrive in the digital pathology industry. This digital pathology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Digital pathology involves utilizing digital imaging for pathology procedures, converting glass slides into high-resolution digital images using slide scanner hardware, software, and related services. These digital images are viewable, manageable, and analyzable on computer or mobile screens.
Key products in digital pathology include scanners, software, communication systems, and storage systems. Scanners utilize microscopic array technology to create three-dimensional digital representations of pathology slides for viewing and automated image analysis. Software aids in transferring data to digital formats for image review, analysis, and tissue image analysis. Communication systems facilitate interaction between various components for slide acquisition, storage, viewing, and real-time telepathology with remote colleagues. Storage systems involve digital archives for long-term sample analysis and predictive analytics. Pathology branches into human pathology and veterinary pathology. Digital pathology finds application across pharmaceutical & biotechnology companies, hospitals, reference laboratories, academic & research institutes. Its uses encompass drug discovery, disease diagnosis, teleconsultation, and training & education purposes.
The digital pathology market consists of the sales of slide scanners, software, and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Digital Pathology Market Characteristics
3. Digital Pathology Market Supply Chain Analysis
4. Global Digital Pathology Market Trends and Strategies
5. Digital Pathology Market Analysis of End Use Industries
7. Global Digital Pathology Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Digital Pathology Total Addressable Market (TAM) Analysis for the Market
9. Digital Pathology Market Segmentation
10. Digital Pathology Market Regional and Country Analysis
11. Asia-Pacific Digital Pathology Market
12. China Digital Pathology Market
13. India Digital Pathology Market
14. Japan Digital Pathology Market
15. Australia Digital Pathology Market
16. Indonesia Digital Pathology Market
17. South Korea Digital Pathology Market
18. Taiwan Digital Pathology Market
19. South East Asia Digital Pathology Market
20. Western Europe Digital Pathology Market
21. UK Digital Pathology Market
22. Germany Digital Pathology Market
23. France Digital Pathology Market
24. Italy Digital Pathology Market
25. Spain Digital Pathology Market
26. Eastern Europe Digital Pathology Market
27. Russia Digital Pathology Market
28. North America Digital Pathology Market
29. USA Digital Pathology Market
30. Canada Digital Pathology Market
31. South America Digital Pathology Market
32. Brazil Digital Pathology Market
33. Middle East Digital Pathology Market
34. Africa Digital Pathology Market
36. Digital Pathology Market Competitive Landscape and Company Profiles
37. Digital Pathology Market Other Major and Innovative Companies
40. Digital Pathology Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Digital Pathology Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses digital pathology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for digital pathology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital pathology market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Scanners; Software; Storage And Communication Systems2) By Pathology Discipline: Human Pathology; Veterinary Pathology
3) By Application: Drug Discovery; Disease Diagnosis; Teleconsultation; Training And Education
4) By End-User: Pharmaceutical And Biotechnology Companies; Hospitals And Reference Laboratories; Academic And Research Institutes
Subsegments:
1) By Scanners: Whole Slide Scanners; Tissue Microarray Scanners; Digital Imaging Systems2) By Software: Image Analysis Software; Workflow Management Software; Diagnostic Software
3) By Storage And Communication Systems: Data Storage Solutions; Cloud-Based Platforms; Network And Communication Systems
Companies Mentioned: Danaher Corporation; Hoffmann-La Roche Ltd; Koninklijke Philips N.V; Hamamatsu Photonics K.K; 3DHISTECH Ltd; Olympus Corporation; Nikon Corporation; Leica Biosystems; Ventana Medical Systems; Sectra AB; Visiopharm A/S; Indica Labs Inc; PathAI; Paige.ai; Ibex Medical Analytics; Aiforia Technologies; Proscia; Inspirata Inc; Huron Digital Pathology; Akoya Biosciences; Aperio Digital Pathology; PerkinElmer; Definiens AG; Digipath; Apollo Enterprise Imaging Corp
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Digital Pathology market report include:- Danaher Corporation
- Hoffmann-La Roche Ltd
- Koninklijke Philips N.V
- Hamamatsu Photonics K.K
- 3DHISTECH Ltd
- Olympus Corporation
- Nikon Corporation
- Leica Biosystems
- Ventana Medical Systems
- Sectra AB
- Visiopharm A/S
- Indica Labs Inc
- PathAI
- Paige.ai
- Ibex Medical Analytics
- Aiforia Technologies
- Proscia
- Inspirata Inc
- Huron Digital Pathology
- Akoya Biosciences
- Aperio Digital Pathology
- PerkinElmer
- Definiens AG
- Digipath
- Apollo Enterprise Imaging Corp
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.68 Billion |
| Forecasted Market Value ( USD | $ 3.29 Billion |
| Compound Annual Growth Rate | 18.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
